← Leaderboards
Ellen L. Goode
Mayo Clinic Rochester
$9,487,134
Attributed
$10,394,650
Total exposure
7
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2007–25$2M$1.5M$1M$500K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$10,394,650 · 7
By mechanism
R01$8,308,578 · 3
P50$1,710,852 · 3
R21$375,220 · 1
Top collaborators
- Lynn C. Hartmann5 shared
- Keith L Knutson5 shared
Most similar at Mayo Clinic Rochester
Same institution · by research overlap
- Stephen Norman Thibodeau$86,704,246
- Robert R McWilliams$655,540
- Scott H Kaufmann$29,002,745
Others in their field
Top investigators on “Woman”
- Chanza Baytop · Westat, Inc.$271,217,917
- Lawrence Corey · Fred Hutchinson Cancer Center$252,110,127
- Wafaa M. El-Sadr · Columbia University Health Sciences$232,152,340
- Myron S Cohen · Family Health International$208,921,087
- Barbara Driver · Westat, Inc.$190,429,693
- Judith S. Currier · University Of California Los Angeles$149,317,678
Research focus
WomanMalignant Neoplasm Of OvaryFutureBaseResearch PersonnelEnvironmentSamplingOvarianClinicGenomicsGenesGeneticResourcesMalignant NeoplasmsTumorMolecularInheritedGrantOvarian NeoplasmQueenslandImmunityMortality Vital StatisticsElementsMalignant Female Reproductive System Neoplasm
Grant awards (26)
Relating Molecular Subgroups of Endometriosis-Associated Ovarian Cancers to Survival and Risk$347,549
R01 · FY2025 · CA · contact PI
Career Enhancement Program$71,141
P50 · FY2025 · CA · contact PI
Relating Molecular Subgroups of Endometriosis-Associated Ovarian Cancers to Survival and Risk$940,822
R01 · FY2024 · CA · contact PI
Relating Molecular Subgroups of Endometriosis-Associated Ovarian Cancers to Survival and Risk$998,385
R01 · FY2023 · CA · contact PI
Relating Molecular Subgroups of Endometriosis-Associated Ovarian Cancers to Survival and Risk$998,304
R01 · FY2022 · CA · contact PI
Relating Molecular Subgroups of Endometriosis-Associated Ovarian Cancers to Survival and Risk$1,070,801
R01 · FY2021 · CA · contact PI
Epidemiology and Genomics of Ovarian Clear Cell Carcinoma$167,725
R21 · FY2019 · CA · contact PI
Career Development$83,804
P50 · FY2019 · CA · contact PI
Epidemiology and Genomics of Ovarian Clear Cell Carcinoma$207,495
R21 · FY2018 · CA · contact PI
Career Development$49,800
P50 · FY2018 · CA · contact PI
Career Development$49,801
P50 · FY2017 · CA · contact PI
Career Development$47,581
P50 · FY2016 · CA · contact PI
Career Development$47,451
P50 · FY2015 · CA · contact PI
Mechanisms of Immune Suppression in Ovarian Cancer$209,136
P50 · FY2013 · CA
Mechanisms of Immune Suppression in Ovarian Cancer$327,530
P50 · FY2012 · CA
Genetic Variation in the NF-kappaB Pathway and Ovarian Cancer Etiology$18,847
R01 · FY2012 · CA · contact PI
Genetic Variation in the NF-kappaB Pathway and Ovarian Cancer Etiology$474,657
R01 · FY2011 · CA · contact PI
Mechanisms of Immune Suppression in Ovarian Cancer$264,989
P50 · FY2011 · CA
Genetic Variation in the NF-kappaB Pathway and Ovarian Cancer Etiology$492,570
R01 · FY2010 · CA · contact PI
Mechanisms of Immune Suppression in Ovarian Cancer$279,645
P50 · FY2010 · CA
Genetic Variation in the NF-kappaB Pathway and Ovarian Cancer Etiology$550,286
R01 · FY2009 · CA · contact PI
Mechanisms of Immune Suppression in Ovarian Cancer$279,974
P50 · FY2009 · CA
GENETIC LINKAGE IN COLORECTAL CANCER FAMILES$612,993
R01 · FY2008 · CA · contact PI
Genetic Variation in the NF-kappaB Pathway and Ovarian Cancer Etiology$548,865
R01 · FY2008 · CA · contact PI
GENETIC LINKAGE IN COLORECTAL CANCER FAMILES$665,730
R01 · FY2007 · CA · contact PI
Genetic Variation in the NF-kappaB Pathway and Ovarian Cancer Etiology$588,769
R01 · FY2007 · CA · contact PI